Pharma tariff stays nil

GENERICS EXEMPTED

- MANU KAUSHIK

INDIA'S EXPORTS OF generic pharmaceuticals to the US will continue to attract zero import duty, as per the interim India-US trade deal. The zero tariff status comes as a big upside for players like Dr Reddy's, Sun Pharma, Lupin, Cipla and Aurobindo Pharma, companies that generate 30-40% of their revenues from the US market, analysts said.